Mendo T, J Clin Stud Med Case Rep 2021, 8: 123 DOI: 10.24966/CSMC-8801/1000123
HSOA Journal of
Clinical Studies and Medical Case Reports Case Report
Neonatal Mastitis to MRSA
Tânia Mendo*, Catarina Borges, Joana Monteiro, Gabriela Reis and Graça Seves Hospital José Joaquim Fernandes, Unidade Local de Saúde do Baixo Alentejo, Beja, PortugalAltamura (Bari), Italy
Abstract Neonatal mastitis is an inflammatory process of the mammary gland, presenting as erythema, edema, hypersensitivity, induration, sometimes with purulent exudate or abscess. It occurs more frequently in female infants, in the 3rd week of life and is usually unilateral. In most cases, the agent involved is Staphylococcus aureus and the clinical evolution is favorable.
Figure 1: Neonate with mastitis
Case Report A 19-day-old newborn twin, with an uneventful early neonatal period and no relevant personal or family history, was observed in the emergency department for skin changes in the right breast. On observation, her breast skin was hyperemic, painful, with purulent exudate. Blood tests revealed 12940/uL leukocytes with 52.9% neutrophils and a CRP of 0.9mg/dL. She performed breast ultrasound which showed “a grossly ovoid hypoechogenic area, close to the surface of the skin” (Figures 1&2). She was admitted on intravenous flucloxacillin, which was replaced on day 3 by vancomycin, due to the isolation of SAMR in the exudate. She completed a 10-day-course of antibiotics. Blood cultures were negative. She was discharged on day 10, clinically improved, with almost complete regression of inflammatory signs and a residual echographic image. SAMR screening was performed on her parents and sister, which was negative [1-3].
Discussion This case is similar to other ones described in literature. Nonetheless, the authors aim to highlight the importance of identifying methicillin-resistant Staphylococcus aureus. MR bacteria are a major health problem and its recent increase in pediatric age is concerning. Isolation of SAMR in a newborn without risk factors raises de possibility of a community/hospital outbreak. Therefore, proper infection control. *Corresponding author: Tânia Mendo, Department of Pediatrics, Hospital José Joaquim Fernandes, Rua Dr. António Fernando Covas Lima, 7801-849 Beja, Portugal, Tel: +351 284310200; Email: mendotania.tfdsm@gmail.com Citation: Mendo T, Borges C, Monteiro J, Reis G, Seves G (2021) Neonatal Mastitis to MRSA. J Clin Stud Med Case Rep 8: 0123. Received: October 06, 2021; Accepted: October 08, 2021; Published: October 15, 2021 Copyright: © 2021 Mendo T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 2: Neonate with mastitis.
Author Disclosure Drs Mendo, Borges, Monteiro, Reis and Seves have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
References 1. Masoodi T, Mufti GN, Bhat JI, Lone R, Arshi S, et al. (2014) Neonatal mastitis: a clinico-microbiological study. J Neonatal Surg 3: 2. 2. Faden H (2005) Mastitis in children from birth to 17 years. Pediatr Infect Dis J 24: 1113. 3. Al Ruwaili N, Scolnik D (2012) Neonatal mastitis: controversies in management. J Clin Neonatol 1: 207-210.